-
Investment type
-
Equity / Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
-
Latest Disclosed Shares Owned
-
7,825,501 shares
-
Security Ownership %
-
8.3%
AstraZeneca PLC ownership in Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
06 Feb 2026 - AstraZeneca PLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,825,501 shares of Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares).
This represents 8.3% ownership of the company.
This is the first filing by ASTRAZENECA PLC disclosing ownership of Innate Pharma SA Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares).